Early Discontinuation and Restart of Insulin in the Treatment of Type 2 Diabetes Mellitus

被引：0
|
作者：
Haya Ascher-Svanum
Maureen J. Lage
Magaly Perez-Nieves
Matthew D. Reaney
Joanne Lorraine
Angel Rodriguez
Michael Treglia
机构：
[1] Global Patient Outcomes and Real World Evidence,
[2] Eli Lilly and Company,undefined
[3] HealthMetrics Outcomes Research,undefined
[4] Eli Lilly and Company,undefined
[5] Eli Lilly Canada,undefined
[6] Eli Lilly Spain,undefined
[7] ERT,undefined
来源：
Diabetes Therapy | 2014年 / 5卷
关键词：
Costs; Early discontinuation; Insulin; Persistence; Restart; Type 2 diabetes mellitus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：225 / 242
页数：17
相关论文
共 50 条
  • [41] Discontinuation of metformin in type 2 diabetes patients treated with insulin
    Wulffelé, MG
    Kooy, A
    Lehert, P
    Bets, D
    Oom, JA
    van der Burg, BB
    Donker, AJM
    Stehouwer, CDA
    NETHERLANDS JOURNAL OF MEDICINE, 2002, 60 (06): : 249 - 252
  • [42] Early detection of cutaneous complications of insulin therapy in type 1 and type 2 diabetes mellitus
    Arora, Saurabh
    Agrawal, Neeraj Kumar
    Shanthaiah, Dhananjaya Melkunte
    Verma, Ashish
    Singh, Sanjay
    Patne, Shashikant C. U.
    Kalra, Sanjay
    Singh, Parminder
    Goyal, Saloni
    PRIMARY CARE DIABETES, 2021, 15 (05) : 859 - 864
  • [43] Insulin treatment and antioxidant status in atherosclerotic patients with diabetes mellitus type 2
    Siemianowicz, K
    Gminski, J
    Telega, A
    Posielezna, B
    Wojcik, A
    Grabowska-Bochenek, R
    Francuz, T
    ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (01) : 152 - 152
  • [44] Newly diagnosed patients with type 2 diabetes mellitus are satisfied with insulin treatment
    Lingvay, I.
    Kaloyanova, P. F.
    Raskin, P.
    DIABETOLOGIA, 2006, 49 : 527 - 527
  • [45] Continuous subcutaneous insulin infusion for treatment of type 2 diabetes mellitus.
    Davidson, PC
    Jeng, L
    Ghegan, M
    Winsett, J
    Bode, BW
    DIABETOLOGIA, 1999, 42 : A212 - A212
  • [46] EFFECT OF INSULIN GLARGINE OR NPH INSULIN ON TREATMENT SATISFACTION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Moock, J.
    Hessel, F.
    Kohlmann, T.
    VALUE IN HEALTH, 2008, 11 (06) : A514 - A514
  • [47] The significance of long acting insulin analogues in the treatment of type 2 diabetes mellitus
    Ludvik, Bernhard
    Brath, Helmut
    Wascher, Thomas
    Toplak, Hermann
    WIENER KLINISCHE WOCHENSCHRIFT, 2009, 121 (13-14) : 473 - 482
  • [48] Lixisenatide as add-on to insulin glargine for the treatment of type 2 diabetes mellitus
    Forst, Thomas
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (12) : 1703 - 1708
  • [49] Treatment Costs of Basal Insulin Regimens for Type 2 Diabetes Mellitus in France
    Bruno Detournay
    Zahra Boultif
    Amar Bahloul
    Viviane Jeanbat
    Julien Robert
    PharmacoEconomics - Open, 2021, 5 : 211 - 219
  • [50] Medically Supervised Fast as a Treatment of Insulin Resistance in Type 2 Diabetes Mellitus
    Becerra, Nancy Mora
    Ruberg, Melinda C.
    Shubrook, Jay H.
    DIABETES, 2014, 63 : A589 - A589
12345